Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Mar 16, 2026 · Filed Mar 18, 2026
The Vita Coco's Chief Operating Officer sold $1.2M of The Vita Coco shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,200,000
Shares × reported transaction price
26 days after results of Feb 18, 2026, 44 days before results of Apr 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −4.3% | −2.2% | −2.0% |
| 30 days | −12.1% | +7.4% | −19.5% |
| 90 days | +55.0% | +12.3% | +42.6% |
| 180 days | +3.3% | +14.8% | −11.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$1.25M of The Vita Coco Company
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.